In a report released yesterday, Myles Minter from William Blair reiterated a Buy rating on Silence Therapeutics (SLN – Research
Author: Howard Kim
Analysts Offer Insights on Healthcare Companies: Larimar Therapeutics (NASDAQ: LRMR), Autolus Therapeutics (NASDAQ: AUTL) and Atea Pharmaceuticals (NASDAQ: AVIR)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Larimar Therapeutics
Analysts Offer Insights on Utilities Companies: EOG Resources (NYSE: EOG) and Marathon Petroleum (NYSE: MPC)
There’s a lot to be optimistic about in the Utilities sector as 2 analysts just weighed in on EOG Resources
Usio (USIO) Gets a Buy Rating from Barrington
In a report released today, Gary Prestopino from Barrington reiterated a Buy rating on Usio (USIO – Research Report), with
AbCellera Biologics (ABCL) Received its Third Buy in a Row
After Leerink Partners and Berenberg Bank gave AbCellera Biologics (NASDAQ: ABCL) a Buy rating last month, the company received another
BMO Capital Thinks Checkmate Pharmaceuticals’ Stock is Going to Recover
In a report released today, Do Kim from BMO Capital assigned a Buy rating to Checkmate Pharmaceuticals (CMPI – Research
Wall Street Analysts Are Neutral on Top Utilities Picks
Analysts fell to the sidelines weighing in on Marathon Oil (MRO – Research Report) and TransAlta (TAC – Research Report)